Pentassuglia Laura, Sawyer Douglas B
Cardiovascular Division, Department of Medicine, Vanderbilt University, Nashville, TN, USA.
Exp Cell Res. 2009 Feb 15;315(4):627-37. doi: 10.1016/j.yexcr.2008.08.015. Epub 2008 Sep 3.
Products of the Neuregulin-1 (Nrg-1) gene, along with the ErbB family of receptor tyrosine kinases through which Nrg-1 ligands signal, play a critical role during cardiovascular development. Through studies of genetically manipulated mice, as well as studies in cells isolated from adult hearts, it appears that Nrg-1/ErbB signaling is an essential paracrine mediator of cell-cell interactions that not only regulates tissue organization during development, but also helps to maintain cardiac function throughout an organism's life. Studies in cells isolated from the heart demonstrate that Nrg-1 can activate a number of signaling pathways, which mediate cellular adaptations to stress in the myocardium. These observations provide insight as to why ErbB2-targeted cancer treatments have deleterious effects on cardiac function in some cancer patients. Moreover emerging data suggest that Nrg-1 ligands might be useful clinically to restore cardiac function after cardiac injury. In this review we will attempt to synthesize the literature behind this rapidly growing and exciting area of research.
神经调节蛋白-1(Nrg-1)基因的产物,与Nrg-1配体通过其进行信号传导的受体酪氨酸激酶ErbB家族一起,在心血管发育过程中发挥关键作用。通过对基因操作小鼠的研究以及对从成年心脏分离出的细胞的研究,似乎Nrg-1/ErbB信号传导是细胞间相互作用的重要旁分泌介质,它不仅在发育过程中调节组织组织,而且有助于在生物体的整个生命过程中维持心脏功能。对从心脏分离出的细胞的研究表明,Nrg-1可以激活多种信号通路,这些信号通路介导心肌细胞对应激的适应性变化。这些观察结果有助于解释为什么针对ErbB2的癌症治疗会对某些癌症患者的心脏功能产生有害影响。此外,新出现的数据表明,Nrg-1配体在临床上可能有助于心脏损伤后恢复心脏功能。在这篇综述中,我们将尝试综合这一快速发展且令人兴奋的研究领域背后的文献。